AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 156 filers reported holding AIMMUNE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $32,623,000 | +59.3% | 974,719 | -0.3% | 0.06% | +41.0% |
| Q3 2019 | $20,478,000 | +33.3% | 977,927 | +32.6% | 0.04% | +34.5% |
| Q2 2019 | $15,357,000 | +21.2% | 737,626 | +30.1% | 0.03% | +16.0% |
| Q1 2019 | $12,671,000 | -11.3% | 566,934 | -5.1% | 0.02% | -26.5% |
| Q4 2018 | $14,291,000 | +8.6% | 597,459 | +23.9% | 0.03% | +30.8% |
| Q3 2018 | $13,154,000 | +0.4% | 482,196 | -1.0% | 0.03% | 0.0% |
| Q2 2018 | $13,103,000 | -9.2% | 487,272 | +7.5% | 0.03% | -16.1% |
| Q1 2018 | $14,429,000 | – | 453,320 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 3,967,900 | $42,933,000 | 29.35% |
| TLP GROUP LLC | 2,833,285 | $30,656,000 | 20.86% |
| Aisling Capital LLC | 2,990,000 | $32,352,000 | 7.64% |
| Vivo Capital, LLC | 763,009 | $8,256,000 | 2.26% |
| RA Capital Management | 1,292,940 | $13,990,000 | 1.94% |
| Foresite Capital Management III, LLC | 235,020 | $2,543,000 | 1.74% |
| Palo Alto Investors LP | 325,599 | $3,523,000 | 0.27% |
| Rock Springs Capital Management LP | 293,000 | $3,170,000 | 0.24% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 332,625 | $3,599,000 | 0.20% |
| Virtus ETF Advisers LLC | 19,501 | $211,000 | 0.16% |